Grants

Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.

Filter By

Year

Topic

Location

Displaying 1 - 10 of 18 results for "Drug Discovery,"

Efficacy of novel 4-drug combinations in the relapsing BALB/c mouse model of TB (GMRI-0007)

Research Grant Start Date:

09/01/2024
Research Topics:
- Tuberculosis
- Drug Discovery
Research Lead Investigators:
- Eric Nuermberger, MD
Harnessing potent next-generation diarylquinolines for long-acting injectable formulations to prevent and treat tuberculosis

Research Grant Start Date:

06/01/2024
Research Topics:
- Tuberculosis
- Drug Discovery
Research Lead Investigators:
- Eric Nuermberger, MD
Amendment 30: TB Alliance Combo Study

Research Grant Start Date:

01/01/2024
Research Topics:
- Tuberculosis
- Drug Discovery
Research Lead Investigators:
- Eric Nuermberger, MD
Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium

Research Grant Start Date:

12/02/2023
Research Topics:
- Tuberculosis
- Drug Discovery
Research Lead Investigators:
- Eric Nuermberger, MD
Assess the activity of MRX-V against M. abscessus

Research Grant Start Date:

03/01/2023
Research Topics:
- Non-Tuberculous Mycobacteria
- Drug Discovery
Research Lead Investigators:
- Gyanu Lamichhane, PhD
Characterizing CaeA-mediated rifampin tolerance in MTB

Research Grant Start Date:

11/10/2022
Research Topics:
- Tuberculosis
- Drug Discovery
Research Lead Investigators:
- Petros Constantine Karakousis, MD
Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP SA02 as an Adjunct to Best Available Antibiotic Therapy Compared to Best Available Antibiotic Therapy Alone for the Treatment of Adults With Bacteremia Due to Staphylococcus aureus

Research Grant Start Date:

08/16/2022
Research Topics:
- Drug Discovery
- Clinical Trials
Research Lead Investigators:
- Mamuka Machaidze, MD
Regimens with omadacycline (OMC) for treatment of Mycobacteroides abscessus disease

Research Grant Start Date:

11/01/2021
Research Topics:
- Non-Tuberculous Mycobacteria
- Drug Discovery
Research Lead Investigators:
- Gyanu Lamichhane, PhD
Preclinical Program for Targeting Myobacterium tuberculosis KasA

Research Grant Start Date:

08/10/2021
Research Topics:
- Tuberculosis
- Drug Discovery
Research Lead Investigators:
- Eric Nuermberger, MD
Harnessing potent next-generation diarylquinolines for long-acting injectable formulations to prevent and treat tuberculosis (Assist # 830011)

Research Grant Start Date:

06/25/2021
Research Topics:
- Tuberculosis
- Drug Discovery
Research Lead Investigators:
- Eric Nuermberger, MD